3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
8
Polycythemia Vera
6
Multiple Myeloma
5
Prostatic Neoplasms
4
Neoplasms
4
Colonic Neoplasms
4
Cardiovascular Diseases
4
Venous Thromboembolism
3
Thrombocythemia, Essential
3
Precancerous Conditions
3
Ovarian Neoplasms
3
Neoplasms, Plasma Cell
3
Myeloproliferative Disorders
3
Melanoma
3
Esophageal Neoplasms
3
Barrett Esophagus
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Adenomatous Polyps
2
Vascular Diseases
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stroke
1
Interventions
Echocardiography
2
liposomal doxorubicin
1
Vitamin E
1
Vitamin D
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Surveys and Questionnaires
1
Progestins
1
Positron-Emission Tomography
1
Nutrition Assessment
1
Methods
1
Mass Screening
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Immunomodulating Agents
1
Immune Checkpoint Inhibitors
1
Hormone Replacement Therapy
1
Hematologic Tests
1
Exercise Test
1
Estrogens
1
Estrogen Replacement Therapy
1
Educational Status
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Calcium
1
Breathing Exercises
1
Blood Specimen Collection
1
Aspirin
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Heart Diseases
×
Aspirin
×
Clear all
NCT00000479
2012-06-15
WHS
Brigham and Women's Hospital
Phase 3
Completed
39,876 enrolled
11 charts